The Janus kinases (JAKs) are essential for cytokine receptor signalling and their dephosphorylation represents a potent inhibitory mechanism. A new paper highlights the T-cell tyrosine phosphatase as an important JAK inhibitor.
release them, so facilitating substrate identification [5] . Using this approach the McGlade group demonstrated that tyrosine phosphorylated Jak1 and Jak3, but not Jak2, selectively bound to the trapping mutant version of TCPTP [3] . Binding was prevented by the addition of orthovanadate, a potent competitive inhibitor of tyrosine phosphatases, confirming that trapping was occurring via the catalytic domain rather than via some other motif. The impressive discrimination of trapping assays was demonstrated by the fact that trapping mutants of two other tyrosine phosphatases, PTP-PEST and PTP-1B, failed to interact with either Jak1 or Jak3. Furthermore, co-transfection of enzymatically active TCPTP with either Jak1 or Jak3 readily caused their dephosphorylation in a cellbased system.
The second approach used to establish Jak1 and Jak3 as TCPTP substrates was to investigate the phosphorylation and activation state of JAKs and STATs in cells from TCPTP-deficient mice. Despite its name, TCPTP is widely expressed in many cell types, with particularly high expression in haematopoietic cells, so unsurprisingly the complex TCPTP-deficient phenotype is characterised by defects in multiple lineages [6] . Using primary TCPTP-deficient cells, the McGlade group found that both Stat1 and Stat5 are hyperphosphorylated, suggesting that TCPTP normally downregulates these pathways. Furthermore, in short-term TCPTP-deficient macrophage cultures, Jak1 but not Jak2 was found to be hyperphosphorylated, consistent with a selective role for TCPTP in dephosphorylating Jak1, as suggested by the trapping results. However, the various results obtained on JAKs and STATs from the TCPTP-deficient mice were from three different cell types (thymocytes, mature T cells and macrophages). Therefore a tight correlation between hyperphosphorylation of a JAK and a STAT in a single cytokine signalling pathway has yet to be elucidated using primary TCPTP-deficient cells. Nevertheless, the trapping mutant and primary TCPTPdeficient cell data taken together [3] do suggest that Jak1 and Jak3 are relevant TCPTP substrates in vivo. Do these findings help to explain the phenotype of TCPTP-deficient mice? Here the situation becomes more tricky. Whereas T-cell development is only mildly perturbed in TCPTP-deficient mice, B-cell development is markedly affected [6] . However, adoptive transfer of TCPTP-deficient bone marrow cells into a wild-type irradiated host, allowed both B and T cells to develop normally, pointing to a defect in the ability of TCPTP-deficient stromal cells to support normal lymphoid cell development. Despite this, mature TCPTPdeficient T and B cells displayed striking defects in their ability to respond to mitogens irrespective of whether they had developed in a TCPTP-deficient or wild-type stromal cell environment [6] . If Jak1 and Jak3 The idea of a tyrosine phosphatase that could play distinctive roles in receptor signalling and in cell-cycle regulation highlights the issue of subcellular localisation. Alternative splicing of TCPTP generates two forms of the enzyme, TCPTPa (45kDa) and TCPTPb (48kDa), which appear to localise to the nucleus and the endoplasmic reticulum, respectively [9,10]. So how does TCPTP reach its putative JAK substrates given that they are associated with the cytoplasmic tails of cytokine receptors? A possible scenario is suggested by a study using EGF-responsive cells in which it was shown that mitogenic stimulation caused the migration of a significant proportion of TCPTP from the nucleus to the cytoplasm [11] . It would be of interest to know whether a similar TCPTP translocation occurs upon antigen receptor stimulation in lymphocytes.
Not surprisingly, there are a number of other candidate JAK tyrosine phosphatases competing for supremacy in the dephosphorylation sweepstakes, as Figure 1 illustrates. A trapping mutant of PTP1B, a tyrosine phosphatase having a high level of homology to TCPTP in its catalytic domain, interacts with Jak2 and Tyk2, but not with Jak1, further underlining phosphatase substrate specificity [12] . Distinctive roles for PTP1B and TCPTP are also suggested by the PTP1B knockout phenotype which is characterised by resistance to diet-induced obesity and diabetes [13] , in contrast to the haematopoietic abnormalities of TCPTP-deficient mice [6] . Whereas TCPTP and PTP1B appear to be neatly complementary with regard to their specificity, the CD45 transmembrane tyrosine phosphatase [14] , restricted in its expression to haematopoietic cells, appears to be capable of dephosphorylating all four JAK family members [15] .
So which phosphatase is more important in regulating JAKs in haematopoietic cells? It is too early to say, but the answer may turn out to be 'it all depends on timing'. CD45 is abundant at the cell surface, so may be used to maintain the cytokine receptor associated pools of JAKs in a low activity state, protecting cells from inappropriate stimulation. In contrast TCPTP could be released from the nucleus to the cytoplasm, following cytokine stimulation and consequent JAK phosphorylation, to act as a classical feedback inhibitor. Earlier literature has also drawn attention to the SHP tyrosine phosphatases as possible JAK regulators (reviewed in [ 1,2] ). There is good evidence that both SHP-1 [16] [17] [18] 
